ImmuCell Corporation Investor Presentation August 2023

ImmuCell Corporation (NASDAQ: ICCC) presented its investor overview in August 2023, covering company strategy, product portfolio including First Defense and Re-Tain, financial performance, and operational updates. The presentation addresses market opportunities in mastitis treatment while discussing manufacturing capacity expansion and supply chain challenges.